Cytotoxicity and DNA interactions of some platinum(II) complexes with substituted benzimidazole ligands

References

• Zhang CX, Lippard SJ. New metal complexes as potential therapeutics. Curr Opin Chem Biol 2003;7:481–489.
   PubMed Web of Science ®Google Scholar
• Fuertes MA, Alonso C, Pérez JM. Biochemical modulation of cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance. Chem Rev 2003;103:645–662.
   PubMed Web of Science ®Google Scholar
• Brabec V, Kasparkova J. Molecular aspects of resistance to antitumor platinum drugs. Drug Resist Updat 2002;5:147–161.
   PubMed Web of Science ®Google Scholar
• Bose RN, Maurmann L, Mishur RJ, Yasui L, Gupta S, Grayburn WS et al. Non-DNA-binding platinum anticancer agents: cytotoxic activities of platinum–phosphato complexes towards human ovarian cancer cells. Proc Natl Acad Sci USA 2008;105:18314–18319.
   PubMed Web of Science ®Google Scholar
• Reardon JT, Vaisman A, Chaney SG, Sancar A. Efficient nucleotide excision repair of cisplatin, oxaliplatin, and bis-aceto-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts. Cancer Res 1999;59:3968–3971.
   PubMed Web of Science ®Google Scholar
• Reedijk J. Why does cisplatin reach guanine-n7 with competing s-donor ligands available in the cell? Chem Rev 1999;99:2499–2510.
   PubMed Web of Science ®Google Scholar
• Kostova I. Platinum complexes as anticancer agents. Recent Pat Anticancer Drug Discov 2006;1:1–22.
   PubMed Web of Science ®Google Scholar
• Gümüş F, İzgü F, Algül Ö. Synthesis and structural characterization of some 5(6)-substituted-2-hydroxymethylbenzimidazole derivatives and their platinum(II) complexes and determination of their in vitro antitumor activities by “Rec-Assay Test”. FABAD Farm Bil Der 1996;21:7–15.
   Google Scholar
• Gümüs F, Pamuk I, Ozden T, Yildiz S, Diril N, Oksüzoglu E et al. Synthesis, characterization and in vitro cytotoxic, mutagenic and antimicrobial activity of platinum(II) complexes with substituted benzimidazole ligands. J Inorg Biochem 2003;94:255–262.
   PubMed Web of Science ®Google Scholar
• Gümüs F, Algül O, Eren G, Eroglu H, Diril N, Gür S et al. Synthesis, cytotoxic activity on MCF-7 cell line and mutagenic activity of platinum(II) complexes with 2-substituted benzimidazole ligands. Eur J Med Chem 2003;38:473–480.
   PubMed Web of Science ®Google Scholar
• Gümüs F, Demirci AB, Ozden T, Eroglu H, Diril N. Synthesis, characterization and mutagenicity of new cis-[Pt(2-substituted-benzimidazole)2Cl2] complexes. Pharmazie 2003;58:303–307.
   PubMed Web of Science ®Google Scholar
• Gökçe M, Utku S, Gür S, Ozkul A, Gümüs F. Synthesis, in vitro cytotoxic and antiviral activity of cis-[Pt(R(−) and S(+)-2-alpha-hydroxybenzylbenzimidazole)2Cl2] complexes. Eur J Med Chem 2005;40:135–141.
   PubMed Web of Science ®Google Scholar
• Algül Ö, Özçelik B, Abbasoğlu U, Gümüş F. Synthesis, characterization and genotoxicity of platinum(II) complexes with substituted benzimidazole ligands. Turk J Chem 2005;29:607–615.
   Web of Science ®Google Scholar
• Utku S, Gümüş F, Gür S, Özkul A. Synthesis and cytotoxic activity of platinum(II) and platinum(IV) complexes with 2-hydroxymethylbenzimidazole or 5(6)-chloro-2-hydroxymethylbenzimidazole ligands against MCF-7 and HeLa cell line. Turk J Chem 2007;31:503–514.
   Web of Science ®Google Scholar
• Gümüs F, Eren G, Açik L, Celebi A, Oztürk F, Yilmaz S et al. Synthesis, cytotoxicity, and DNA interactions of new cisplatin analogues containing substituted benzimidazole ligands. J Med Chem 2009;52:1345–1357.
   PubMed Web of Science ®Google Scholar
• Utku S, Gumus F, Tezcan S, Serin MS, Ozkul A. Synthesis, characterization, cytotoxicity, and DNA binding of some new platinum(II) and platinum(IV) complexes with benzimidazole ligands. J Enzyme Inhib Med Chem 2010;25:502–508.
   PubMed Web of Science ®Google Scholar
• Holst-Hansen C, Brünner N. Cell and tissue culture and associated techniques. Cell Biol 1998;1:16–18.
   Google Scholar
• Maniatis T, Fristsh EF, Sambrook J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, New York, 1989.
   Google Scholar
• Wang D, Lippard SJ. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 2005;4:307–320.
   PubMed Web of Science ®Google Scholar
• Bierbach U, Qu Y, Hambley TW, Peroutka J, Nguyen HL, Doedee M et al. Synthesis, structure, biological activity, and DNA binding of platinum(II) complexes of the type trans-[PtCl(2)(NH(3))L] (L = planar nitrogen base). Effect of L and cis/trans isomerism on sequence specificity and unwinding properties observed in globally platinated DNA. Inorg Chem 1999;38:3535–3542.
   PubMed Web of Science ®Google Scholar
• Roberts RJ, Wilson GA, Young FE. Recognition sequence of specific endonuclease BamHI from Bacillus amyloliquefaciens H. Nature 1977;265:82–84.
   PubMed Web of Science ®Google Scholar
• Brabec V, Kasparkova J. Modifications of DNA by platinum complexes. Relation to resistance of tumors to platinum antitumor drugs. Drug Resist Updat 2005;8:131–146.
   PubMed Web of Science ®Google Scholar
• Fuertes MA, Castilla J, Alonso C, Pérez JM. Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways. Curr Med Chem 2003;10:257–266.
   PubMed Web of Science ®Google Scholar
• Yang D, van Boom SS, Reedijk J, van Boom JH, Wang AH. Structure and isomerization of an intrastrand cisplatin–cross-linked octamer DNA duplex by NMR analysis. Biochemistry 1995;34:12912–12920.
   PubMed Web of Science ®Google Scholar
• Takahara PM, Rosenzweig AC, Frederick CA, Lippard SJ. Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin. Nature 1995;377:649–652.
   PubMed Web of Science ®Google Scholar
• Souchard JP, Ha TT, Cros S, Johnson NP. Hydrophobicity parameters for platinum complexes. J Med Chem 1991;34:863–864.
   PubMed Web of Science ®Google Scholar
• Lu Y, Shi T, Wang Y, Yang H, Yan X, Luo X et al. Halogen bonding—a novel interaction for rational drug design? J Med Chem 2009;52:2854–2862.
   PubMed Web of Science ®Google Scholar
• Khazanov E, Barenholz Y, Gibson D, Najajreh Y. Novel apoptosis-inducing trans-platinum piperidine derivatives: synthesis and biological characterization. J Med Chem 2002;45:5196–5204.
   PubMed Web of Science ®Google Scholar